CNTX Earnings

Quarterly EPS
$-0.22
Q3 2024
$-0.04
Q4 2024
$-0.05
Q1 2025
$-0.09
Q2 2025
$-0.10
Q3 2025
$-0.14
Q4 2025
$-0.09
Q1 2026
$-0.15
Q2 2026
Latest RevenueN/A
Latest Net Income-14558426
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.150-14558426-66.7%
Q1 2026-$0.090-8680572-80.0%
Q4 2025-$0.140-13025607-250.0%
Q3 2025-$0.100-9693237+54.5%
Q2 2025-$0.090-8827510-125.0%
Q1 2025-$0.050-4577261+78.3%
Q4 2024-$0.040-3342908+90.5%
Q3 2024-$0.220-17459893+40.5%
Q2 2024-$0.040-2254506
Q1 2024-$0.230-3667797
Q4 2023-$0.420-6769886
Q3 2023-$0.370-5874686
Context Therapeutics (CNTX) — Earnings